Revance Therapeutics Inc. (RVNC) Moves Higher on Volume Spike for November 16

Equities Staff  |

Revance Therapeutics Inc. (RVNC) traded on unusually high volume on Nov. 16, as the stock gained 2.2% to close at $25.50. On the day, Revance Therapeutics Inc. saw 316,880 shares trade hands on 2,597 trades. Considering that the stock averages only a daily volume of 148,476 shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $28.75 and $15.85 over the last 52-weeks, its 50-day SMA is now $26.06, and its 200-day SMA $23.13. Revance Therapeutics Inc. has a P/B ratio of 5.56.

Revance Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.

Headquartered in Newark, CA, Revance Therapeutics Inc. has 126 employees and is currently under the leadership of CEO L. Daniel Browne.

For a complete fundamental analysis analysis of Revance Therapeutics Inc., check out’s Stock Valuation Analysis report for RVNC.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.

To get more information on Revance Therapeutics Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: RVNC’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Global Cannabis

Global Cannabis Applications Corp is engaged in the design, acquire data and develop applications for smartphones and tablets. The company offer Citizen Green platform, an end to end infrastructure to…